Literature DB >> 8075876

The effect of leukocyte depletion on pulmonary M2 muscarinic receptor function in parainfluenza virus-infected guinea-pigs.

A D Fryer1, K A Yarkony, D B Jacoby.   

Abstract

1. Parainfluenza infections of the airways cause dysfunction of inhibitory M2 muscarinic receptors on the pulmonary parasympathetic nerves. To distinguish the direct effects of virus from the effects of virus-induced airway inflammation on M2 muscarinic receptor function, guinea-pigs were depleted of leukocytes by pretreating with cyclophosphamide (30 mg kg-1, i.p. daily for 7 days) after which they were infected with parainfluenza virus type 1 (Sendai virus). 2. Guinea-pigs were anaesthetized, tracheotomized, and ventilated. The vagus nerves were isolated and cut, and the distal ends were electrically stimulated causing bronchoconstriction. In control animals, pilocarpine (1-100 micrograms kg-1, i.v.) inhibited and gallamine (0.1-10 mg kg-1, i.v.) potentiated vagally-induced bronchoconstriction by stimulating or blocking M2 muscarinic receptors on the vagus. These effects of pilocarpine and gallamine were almost completely lost in virus-infected animals, demonstrating loss of M2 receptor function. 3. Cyclophosphamide depleted peripheral blood leukocytes and inhibited the virus-induced influx of inflammatory cells into the lung. Depletion of leukocytes protected M2 receptor function from viral infection in some, but not all, guinea-pigs tested. 4. Among infected animals that had been depleted of leukocytes, the viral content (expressed as the log of the number of tissue culture infectious doses per g lung tissue) of those that retained normal M2 receptor function was 4.29 +/- 0.05 (mean +/- s.e. mean), while the viral content of those that lost M2 receptor function despite leukocyte depletion was 5.45 +/- 0.20 (P = 0.011). Thus the viral content of the lungs in which M2 receptor function was lost was 16 times greater than that of the lungs in which M2 receptor function was preserved. Viral content correlated with the inhibition of vagally-mediated bronchoconstriction after the maximum dose of pilocarpine (100 Microg kg-1; r2 = 0.81, P =0.0004).5. In antigen-challenged animals, inhibitory M2 muscarinic receptor function is restored when positively charged inflammatory cell proteins are bound and neutralized by heparin. However, heparin(2000 micro kg-1, i.v.) did not reverse virus-induced loss of M2 muscarinic receptor function, even in those guinea-pigs with a lower viral titer.6. Because leukocyte depletion protected M2 muscarinic receptor function only in animals with mild viral infections, it appears that viruses have both an indirect, leukocyte-dependent effect on M2 receptors and, in animals with more severe infections, a leukocyte-independent effect on M2 receptors. The failure of heparin to restore M2 receptor function demonstrates that the leukocyte-dependent loss of M2 receptor function is not mediated by positively charged inflammatory cell proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8075876      PMCID: PMC1910393          DOI: 10.1111/j.1476-5381.1994.tb13115.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Contributions to the physiology of the lungs: Part I. The bronchial muscles, their innervation, and the action of drugs upon them.

Authors:  W E Dixon
Journal:  J Physiol       Date:  1903-03-16       Impact factor: 5.182

2.  Pulmonary function in uncomplicated influenza.

Authors:  W G Johanson; A K Pierce; J P Sanford
Journal:  Am Rev Respir Dis       Date:  1969-08

Review 3.  Upper respiratory infections in asthma.

Authors:  R C Welliver
Journal:  J Allergy Clin Immunol       Date:  1983-10       Impact factor: 10.793

4.  Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart.

Authors:  A D Fryer; E E el-Fakahany; D B Jacoby
Journal:  Eur J Pharmacol       Date:  1990-05-31       Impact factor: 4.432

5.  Airway reactivity in subjects with viral upper respiratory tract infections: the effects of exercise and cold air.

Authors:  A T Aquilina; W J Hall; R G Douglas; M J Utell
Journal:  Am Rev Respir Dis       Date:  1980-07

6.  Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor.

Authors:  D B Jacoby; G J Gleich; A D Fryer
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Dysfunction of M2-muscarinic receptors in pulmonary parasympathetic nerves after antigen challenge.

Authors:  A D Fryer; M Wills-Karp
Journal:  J Appl Physiol (1985)       Date:  1991-12

8.  In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity.

Authors:  C K Buckner; V Songsiridej; E C Dick; W W Busse
Journal:  Am Rev Respir Dis       Date:  1985-08

9.  Neuronal muscarinic receptors attenuate vagally-induced contraction of feline bronchial smooth muscle.

Authors:  L C Blaber; A D Fryer; J Maclagan
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

10.  Parainfluenza 3 infection blocks the ability of a beta adrenergic receptor agonist to inhibit antigen-induced contraction of guinea pig isolated airway smooth muscle.

Authors:  C K Buckner; D E Clayton; A A Ain-Shoka; W W Busse; E C Dick; P Shult
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

View more
  11 in total

Review 1.  Neural control of airway inflammation.

Authors:  Kirsten C Verhein; Allison D Fryer; David B Jacoby
Journal:  Curr Allergy Asthma Rep       Date:  2009-11       Impact factor: 4.806

Review 2.  Mechanisms of virus induced exacerbations of asthma.

Authors:  J M Corne; S T Holgate
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

3.  Allergic inflammation induces a persistent mechanistic switch in thromboxane-mediated airway constriction in the mouse.

Authors:  Jaime M Cyphert; Irving C Allen; Rachel J Church; Anne M Latour; John N Snouwaert; Thomas M Coffman; Beverly H Koller
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-07       Impact factor: 5.464

4.  Viral infection induces dependence of neuronal M2 muscarinic receptors on cyclooxygenase in guinea pig lung.

Authors:  R M Kahn; O A Okanlami; D B Jacoby; A D Fryer
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

5.  Toll-like receptor-2/6 and Toll-like receptor-9 agonists suppress viral replication but not airway hyperreactivity in guinea pigs.

Authors:  Matthew G Drake; Scott E Evans; Burton F Dickey; Allison D Fryer; David B Jacoby
Journal:  Am J Respir Cell Mol Biol       Date:  2013-06       Impact factor: 6.914

6.  Virus- and interferon-induced loss of inhibitory M2 muscarinic receptor function and gene expression in cultured airway parasympathetic neurons.

Authors:  D B Jacoby; H Q Xiao; N H Lee; Y Chan-Li; A D Fryer
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

7.  Interleukin-1β mediates virus-induced m2 muscarinic receptor dysfunction and airway hyperreactivity.

Authors:  Abby E Rynko; Allison D Fryer; David B Jacoby
Journal:  Am J Respir Cell Mol Biol       Date:  2014-10       Impact factor: 6.914

8.  Retinoic acid prevents virus-induced airway hyperreactivity and M2 receptor dysfunction via anti-inflammatory and antiviral effects.

Authors:  Liliana Moreno-Vinasco; Norah G Verbout; Allison D Fryer; David B Jacoby
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-22       Impact factor: 5.464

Review 9.  Mini review: Neural mechanisms underlying airway hyperresponsiveness.

Authors:  Alexandra B Pincus; Allison D Fryer; David B Jacoby
Journal:  Neurosci Lett       Date:  2021-03-02       Impact factor: 3.046

10.  Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects.

Authors:  D J Adamko; B L Yost; G J Gleich; A D Fryer; D B Jacoby
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.